2006
DOI: 10.1016/j.bbrc.2006.03.035
|View full text |Cite
|
Sign up to set email alerts
|

Factors affecting the performance of different long terminal repeats in the retroviral vector

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
10
0

Year Published

2008
2008
2012
2012

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 10 publications
(10 citation statements)
references
References 22 publications
0
10
0
Order By: Relevance
“…We employed a strong MSCV promoter in our vectors, and the previous group used the spleen focus-forming virus promoter (3). However, expression from these two promoters has been shown to be comparable on May 9, 2018 by guest http://jvi.asm.org/ (28). Instead, the most likely explanation is that the prior study used unconcentrated vector stocks with undetermined titers, while we concentrated our NIFV vectors more than 100-fold and infected with known MOIs of genome-containing particles.…”
Section: Discussionmentioning
confidence: 94%
“…We employed a strong MSCV promoter in our vectors, and the previous group used the spleen focus-forming virus promoter (3). However, expression from these two promoters has been shown to be comparable on May 9, 2018 by guest http://jvi.asm.org/ (28). Instead, the most likely explanation is that the prior study used unconcentrated vector stocks with undetermined titers, while we concentrated our NIFV vectors more than 100-fold and infected with known MOIs of genome-containing particles.…”
Section: Discussionmentioning
confidence: 94%
“…Four of them have the same backbone called MT, except for the 3¢ LTR region. 5 MT is a minimum size Moloney murine leukemia virus (MoMLV)-based vector containing no viral coding sequences. 6 The MoMLV 3¢LTR of MT was replaced with LTRs from MSCV, myeloproliferative sarcoma virus (MPSV) and spleen focus-forming virus (SFFV) to produce three different retroviral vectors called MS, MP and MF, respectively ( Figure 1).…”
Section: Retroviral Vectors Used In the Studymentioning
confidence: 99%
“…2,5 The eGFP sequence was amplified using primers eGFP5 (5¢-ACGCGTGGATCCATGGTG AGCAAGGGCGAG-3¢) and eGFP3 (5¢-CTCGAGAGATCTTTACTTGTAC AGCTCGTC-3¢) with pIRES2 (internal ribosomal entry site)-EGFP (Clontech, Palo Alto, CA, USA) as a template. The amplified eGFP sequence was initially cloned into pGem T easy (Promega, Madison, WI, USA), resulting in pGem T easy-eGFP.…”
Section: Construction Of Retroviral Vectorsmentioning
confidence: 99%
See 1 more Smart Citation
“…17 TCR a and b genes were amplified by reverse transcription-PCR and identified as TRAV8-1 and TRBV7-9, respectively. 18 The individual TCR genes were cloned into retroviral vector pMSP, 18,33 harboring a murine stem cell virus long terminal repeat and a murine phosphoglycerate kinase promoter, to produce MS-bPa, in which murine stem cell virus long terminal repeat drives b gene and phosphoglycerate kinase promoter drives a gene. PG13 producer clones were generated and screened to produce high titer virus (Figure 2a).…”
Section: Generation Of Gd T Cellsmentioning
confidence: 99%